TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | -1 | -20 | -29 | -14 | -64 | -21 |
| P | %wins | 100 | 0 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/22 06:06 | 3/2/22 | HGEN | Humanigen, Inc | DE | Health | Drug | Pharmaceutical Preparations | Durrant Cameron | NJ | DO | CEO | P | 94 | 2.34 | 0 | 40 | 133 | 70 | I | ||||||||||||||
6/16/21 21:40 | 6/14/21 | HGEN | Humanigen, Inc | DE | Health | Drug | Pharmaceutical Preparations | Durrant Cameron | CA | DO | CEO | S | -1,681 | 20.64 | 0 | -81 | -73 | 30 | M | ||||||||||||||
12/3/14 17:00 | 11/26/14 | IMNP | Immune Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Durrant Cameron | MA | D | P.d | 10 | 2.50 | 0 | 4 | New | 4 | D | -18 | 49 | 3 | -28 | -11 | -9 | 2 | 0 | 2 | -1 | -20 | -29 | -14 | -64 | |
4/8/13 13:55 | 4/5/13 | PEDX | Pediatrx Inc. | NV | Health | Drug | Pharmaceutical Preparations | Durrant Cameron | NJ | DOT | P,CEO,CF | P | 51 | 0.0120 | 0 | 4,250 | New | 4,250 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |